BioSpace News Archive

Business

Accelerate Diagnostics Schedules Call to Review 3rd Quarter 2021 Results

Accelerate Diagnostics, Inc. announced today that management will host a conference call on Tuesday, November 9, 2021, at 4:30 p.m. Eastern Time to review 2021 third quarter financial results.

October 19, 2021
·
1 min read
Biotech Bay

Purigen Biosystems Enables Scientists to Extract and Purify Higher Yields of DNA from Fresh Frozen Tissue Samples

Purigen Biosystems, Inc. today announced the launch of the Ionic® Tissue to Pure DNA Kit.

October 19, 2021
·
3 min read
Genetown

Vertex to Present Long-Term Data Demonstrating Significant Benefits of Treatment With CFTR Modulators at North American Cystic Fibrosis Conference (NACFC)

Vertex Pharmaceuticals Incorporated today announced that five scientific abstracts about the company’s portfolio of cystic fibrosis (CF) medicines will be presented at the 2021 North American Cystic Fibrosis Conference (NACFC) taking place virtually November 2-5, 2021.

October 19, 2021
·
14 min read
Business

IASO Bio Appoints Industry Veteran Dr. Alan Fu Chief Financial Officer

IASO Biotherapeutics has appointed Dr. Alan Fu as Chief Financial Officer (CFO), reporting to Maxwell Wang, CEO, IASO Bio.

October 19, 2021
·
4 min read
Biotech Bay

Better Therapeutics Enrolls First Patient in Real-World Evidence Study with Catalyst Health Network Evaluating BT-001, a Prescription Digital Therapeutic for Type 2 Diabetes

Better Therapeutics, Inc today announced the first patient has been enrolled in a real-world evidence study to evaluate the long-term effectiveness and healthcare utilization changes associated with the use of BT-001 for the treatment of type 2 diabetes.

October 19, 2021
·
12 min read
Biotech Bay

ReCode Therapeutics to Present Preclinical Data from mRNA-based Program for Cystic Fibrosis at Upcoming Virtual 2021 North American Cystic Fibrosis Conference

ReCode Therapeutics today announced that it will present preclinical data from its mRNA-based therapeutic program for cystic fibrosis (CF) in a poster presentation at the upcoming 2021 North American Cystic Fibrosis Conference (NACFC) to be held virtually from November 2-5, 2021.

October 19, 2021
·
1 min read
Genetown

Gamida Cell to Present at Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting

Gamida Cell to Present at Society for Immunotherapy of Cancer’s (SITC) 36 th Annual Meeting

October 19, 2021
·
4 min read
Business

Libra Therapeutics Appoints Philip Lambert, Ph.D., as Chief Scientific Officer

Libra Therapeutics, Inc. today announced the appointment of Philip Lambert, Ph.D., as the company’s first chief scientific officer.

October 19, 2021
·
2 min read
Biotech Bay

Gilead Sciences Announces Veklury® Donations to Help Address the Ongoing COVID-19 Crisis in Indonesia and Armenia

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company will donate 100,000 vials of Veklury® (remdesivir) to help address the recent surge of COVID-19 cases in Indonesia and 3,000 vials of Veklury to help patients hospitalized with COVID-19 in Armenia.

October 19, 2021
·
5 min read
Press Releases

Sana Biotechnology Obtains a Non-Exclusive License to CRISPR Cas12b Gene Editing Technology from Beam Therapeutics to Enable Engineered Cell Programs

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that the company entered into an agreement with Beam Therapeutics Inc. (NASDAQ: BEAM) for non-exclusive commercial rights to Beam’s CRISPR Cas12b nuclease system for certain ex vivo engineered cell therapy programs.

October 19, 2021
·
4 min read